The U.S. SGLT2 Inhibitors Market is projected to grow from USD 5.49 Billion in 2025 to USD 11.06 Billion by 2035, while ...
A new Kimberley-based study is helping Aboriginal people living with diabetes-related foot disease (DFD) by identifying ways ...
A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results